EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) announced plans to participate in several investor conferences ...

Drugmakers are investing more in U.S. manufacturing as President Donald Trump threatens tariffs, but facilities can take ...

Climate change-driven weather disasters like hurricanes, wildfires and floods pose an immediate threat to the U.S. drug ...

Setmelanotide is a melanocortin-4 receptor (MC4R) agonist, previously approved as IMCIVREE ® by the FDA, the EMA, and UK’s Medicines & Healthcare Products Regulatory Agency (MHRA) for obesity due to ...

As China rises and other global cities aggressively court biotech talent, Massachusetts faces a "contracting moment" that has ...

A webcast of the H.C. Wainwright presentation will be available on September 9 at 12:00 PM EDT. The webcast will be available to watch live and a replay will be available for approximately 90-days ...

A joint venture led by locally based REIT Diversified Healthcare Trust (NASDAQ: DHC) has received $1 billion for the refinancing of the Vertex Pharmaceuticals headquarters facility in Boston. A ...

The RMR Group secured a $1 billion refinancing for Vertex Pharmaceuticals' Boston Seaport headquarters, a five-year, interest ...

Newton-based RMR Group refinanced its Boston Fan Pier property for $1 billion, a year after Vertex Pharmaceuticals renewed ...